A/G Ratio (Albumin/Globulin Ratio)

WBC (White Blood Cell Count)

Neutrophils (Absolute)

Immature Granulocytes

RBC (Red Blood Cell Count)

Phosphorous

Free T4 (Thyroxine)

ALT (Alanine Aminotransferase)

Triglycerides

Lipoprotein(a) [Lp(a)]

MCH (Mean Corpuscular Hemoglobin)

LDH (Lactate Dehydrogenase)

Uric Acid

MCV (Mean Corpuscular Volume)

Platelet Count

Fasting Insulin

Hemoglobin

GGT (Gamma-Glutamyl Transferase)

Chloride

UIBC (Unsaturated Iron Binding Capacity)

MCHC (Mean Corpuscular Hemoglobin Concentration)

Free Testosterone

VLDL Cholesterol (calculated)

eGFR (Estimated Glomerular Filtration Rate)

Vitamin A (Retinol)

SHBG (Sex Hormone Binding Globulin)

IL-6 (Interleukin-6)

Apolipoprotein B

AST (Aspartate Aminotransferase)

Sed Rate (Erythrocyte Sedimentation Rate)

TNF-α (Tumor Necrosis Factor-alpha)

LDL Particle Size

EPA (Eicosapentaenoic Acid)

Creatinine

TSH (Thyroid Stimulating Hormone)

DHA (Docosahexaenoic Acid)

IGF-1 (Insulin-Like Growth Factor 1)

DHEA-S (Dehydroepiandrosterone Sulfate)

Hemoglobin A1C

Reverse T3 (rT3)

Apolipoprotein A1 is a biomarker used in longevity research to assess cardiovascular health and predict risk of age-related diseases.

Apolipoprotein A1

Apolipoprotein A1 is a critical biomarker used in assessing the risk of cardiovascular diseases and overall longevity. It is a major component of high-density lipoprotein (HDL) particles and plays a central role in the reverse cholesterol transport pathway. Higher levels of Apolipoprotein A1 are associated with a reduced risk of developing heart diseases and are considered a favorable biomarker for longevity. Studies have shown that individuals with higher Apolipoprotein A1 levels tend to live longer and have better cardiovascular health. Thus, monitoring Apolipoprotein A1 levels can provide valuable insights into an individual’s potential for living a longer and healthier life.

Biomarker Explained

Apolipoprotein A1 is a crucial biomarker used in assessing an individual’s potential for longevity. This biomarker is a major component of high-density lipoprotein (HDL) particles and plays a central role in the reverse cholesterol transport pathway. Higher levels of Apolipoprotein A1 are associated with a reduced risk of developing heart diseases, making it a favorable biomarker for longevity. Studies have demonstrated that individuals with higher Apolipoprotein A1 levels tend to live longer and have better cardiovascular health. Therefore, monitoring Apolipoprotein A1 levels can provide valuable insights into an individual’s potential for living a longer and healthier life. Assessing the levels of Apolipoprotein A1 in an individual’s blood can help predict their risk of cardiovascular diseases and overall longevity. It is essential to consider this biomarker in combination with other relevant factors to gain a comprehensive understanding of an individual’s potential for longevity.

Keywords:

Apolipoprotein A1, longevity, biomarker, high-density lipoprotein (HDL), reverse cholesterol transport, cardiovascular health, potential for living longer

Contact

Questions, suggestions, reflections?

Fill out the form below and a member of our team well get back to you as soon as possible.

Contact Form (#14)

How does Rapaymcin work?

Rapamycin slows aging by targeting the mTOR pathway, shifting the body’s focus from growth to repair. It promotes cellular recycling, reduces overgrowth linked to disease, and enhances resilience to stress.

Imagine your body as a city, bustling with activity.

Cells are the workers, and mTOR (mechanistic target of rapamycin) is the city planner, deciding where to focus resources – building new structures, cleaning up waste, or repairing old ones.

As we age, mTOR often prioritizes building (cell growth) over maintenance (cellular repair), leading to “clutter” in our bodies that contributes to aging and disease.

This is where Rapamycin comes in.

It acts like a wise advisor to mTOR, convincing it to slow down unnecessary growth projects and focus on clean up and repair instead.

Specifically, Rapamycin:

Activates cellular recycling (autophagy):

Think of autophagy as the city’s waste management system. Damaged parts of cells are broken down and reused, keeping the system efficient and healthy.

Reduces harmful overgrowth:

Overactive mTOR has been linked to diseases such as cancer, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. By dialing back excessive growth signals, Rapamycin helps prevent these issues.

Supports stress resilience:

When cells are less focused on growing, they’re better equipped to handle stress, repair damage, and maintain long-term health.